{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:05Z","timestamp":1793298785880,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD), or infection (INFXN). Previous research indicates that donor-derived cell-free DNA (dd-cfDNA) is a promising noninvasive biomarker for the detection of AR and allograft injury. Our aim was to validate a clinical plasma dd-cfDNA assay for detection of AR and other allograft injury and to confirm and expand on dd-cfDNA and allograft injury associations observed in previous studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We measured dd-cfDNA fraction using a novel single-nucleotide polymorphism-based assay in prospectively collected plasma samples paired with clinical-pathologic diagnoses. dd-cfDNA fraction was compared across clinical-pathologic cohorts: stable, ACR, AMR, isolated lymphocytic bronchiolitis, CLAD\/neutrophilic-responsive allograft dysfunction (NRAD), and INFXN. Performance characteristics were calculated for AR and combined allograft injury (AR + CLAD\/NRAD + INFXN) versus the stable cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The study included 195 samples from 103 patients. Median dd-cfDNA fraction was significantly higher for ACR (1.43%, interquartile range [IQR]: 0.67%\u20132.32%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 5\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>), AMR (2.50%, IQR: 2.06%\u20133.79%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 2\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup>), INFXN (0.74%, IQR: 0.46%\u20131.38%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02), and CLAD\/NRAD (1.60%, IQR: 0.57%\u20132.60%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 1.4\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>) versus the stable cohort. Area under the receiver operator characteristic curve for AR versus stable was 0.91 (95% confidence interval [CI]: 0.83-0.98). Using a \u22651% dd-cfDNA fraction threshold, sensitivity for AR was 89.1% (95% CI: 76.2%-100.0%), specificity 82.9% (95% CI: 73.3%-92.4%), positive predictive value, 51.9% (95% CI: 37.5%-66.3%), and negative predictive value, 97.3% (95% CI: 94.3%-100%). For combined allograft injury area under the receiver operator characteristic curve was 0.76 (95% CI: 0.66-0.85), sensitivity 59.9% (95% CI: 46.0%-73.9%), specificity 83.9% (95% CI: 74.1%-93.7%), positive predictive value, 43.6% (95% CI: 27.6%-59.6%), and negative predictive value, 91.0% (95% CI: 87.9%-94.0%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>These results indicate that our dd-cfDNA assay detects AR and other allograft injury. dd-cfDNA monitoring, accompanied by standard clinical assessments, represents a valuable precision tool to support lung transplant health and is appropriate for further assessment in a prospective randomized-controlled study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001317","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:00:11Z","timestamp":1648486811000},"page":"e1317","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant"],"prefix":"10.1097","volume":"8","author":[{"given":"Justin P.","family":"Rosenheck","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Ross","sequence":"additional","affiliation":[{"name":"Medical Affairs, Natera, Inc. San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mena","family":"Botros","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Ohio State University, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sternberg","sequence":"additional","affiliation":[{"name":"Medical Affairs, Natera, Inc. San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-An","family":"Chen","sequence":"additional","affiliation":[{"name":"R&D, Natera, Inc., San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Liang","sequence":"additional","affiliation":[{"name":"R&D, Natera, Inc., San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Baer","sequence":"additional","affiliation":[{"name":"R&D, Natera, Inc., San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebad","family":"Ahmed","sequence":"additional","affiliation":[{"name":"R&D, Natera, Inc., San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Swenerton","sequence":"additional","affiliation":[{"name":"R&D, Natera, Inc., San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard G.","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"R&D, Natera, Inc., San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Fehringer","sequence":"additional","affiliation":[{"name":"Medical Affairs, Natera, Inc. San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary P.","family":"Demko","sequence":"additional","affiliation":[{"name":"Medical Affairs, Natera, Inc. San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Olymbios","sequence":"additional","affiliation":[{"name":"Medical Affairs, Natera, Inc. San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Billings","sequence":"additional","affiliation":[{"name":"Medical Affairs, Natera, Inc. San Carlos, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Keller","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/1526924816679840","article-title":"Missing domains of lung transplant patient selection.","volume":"27","author":"Blumenthal","year":"2017","journal-title":"Prog Transplant"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014\u2013an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.","volume":"34","author":"Weill","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.healun.2018.07.020","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: multiorgan transplantation.","volume":"37","author":"Chambers","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: donor and recipient size match.","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/TP.0000000000003213","article-title":"The impact of inadequate (\u201cAX\u201d) transbronchial biopsies on post-lung transplant CLAD or death.","volume":"105","author":"Levy","year":"2021","journal-title":"Transplantation"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-6143.2010.03382.x","article-title":"Pathologic interpretation of transbronchial biopsy for acute rejection of lung allograft is highly variable.","volume":"11","author":"Arcasoy","year":"2011","journal-title":"Am J Transplant"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.athoracsur.2019.04.096","article-title":"Optimization of transbronchial cryobiopsy in lung transplant recipients.","volume":"108","author":"Loor","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis.","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ebiom.2018.12.029","article-title":"Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.","volume":"40","author":"Agbor-Enoh","year":"2019","journal-title":"Ebiomedicine"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation.","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.healun.2021.02.008","article-title":"Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).","volume":"40","author":"Keller","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"00462","DOI":"10.1183\/23120541.00462-2020","article-title":"Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation.","volume":"7","author":"Khush","year":"2021","journal-title":"ERJ Open Res"},{"key":"R13-20240805","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2021.12.009","article-title":"Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.","author":"Keller","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR.","volume":"8","author":"Sigdel","year":"2018","journal-title":"J Clin Med"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/17476348.2021.1913058","article-title":"Bronchoscopy during the COVID-19 pandemic: effect on current practices and strategies to reduce procedure-associated transmission.","volume":"15","author":"Sampsonas","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1378\/chest.10-3361","article-title":"American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients.","volume":"140","author":"Wahidi","year":"2011","journal-title":"Chest"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.healun.2020.07.006","article-title":"International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation.","volume":"39","author":"Martinu","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation.","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients.","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R22-20240805","first-page":"54","article-title":"Bootsrap methods for standard errors confidence intervals and other measures of statistical accuracy.","volume":"1","author":"Efron","year":"1986","journal-title":"Stat Sci"},{"issue":"suppl 2","key":"R23-20240805","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ajt.16495","article-title":"OPTN\/SRTR 2019 annual data report: lung.","volume":"21","author":"Velapour","year":"2021","journal-title":"Am J Transplant"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.healun.2017.05.026","article-title":"Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.","volume":"36","author":"Agbor-Enoh","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.healun.2009.01.014","article-title":"Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.","volume":"28","author":"Neurohr","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0033-1348463","article-title":"Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).","volume":"34","author":"Verleden","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/ajt.12091","article-title":"Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.","volume":"13","author":"Kennedy","year":"2013","journal-title":"Am J Transplant"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2021.03.007","article-title":"Cell-free DNA beyond a biomarker for rejection: biological trigger of tissue injury and potential therapeutics.","volume":"40","author":"Tsuji","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R30-20240805","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.healun.2021.05.012","article-title":"Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.","volume":"40","author":"Bazemore","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200706-951OC","article-title":"Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.","volume":"177","author":"Glanville","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R32-20240805","first-page":"832","article-title":"\u201cRefractoriness\u201d of airflow obstruction associated with isolated lymphocytic bronchiolitis\/bronchitis in pulmonary allografts.","volume":"16","author":"Ross","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1097\/TXD.0000000000001063","article-title":"Plasma donor-derived cell-free DNA levels are increased during acute cellular rejection after lung transplant: pilot data.","volume":"6","author":"Sayah","year":"2020","journal-title":"Transplant Direct"},{"key":"R34-20240805","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-5223(19)36386-X","article-title":"Dilatation, compensatory growth, or both after pneumonectomy during childhood and adolescence. A thirty-year follow-up study.","volume":"93","author":"Laros","year":"1987","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R35-20240805","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1152\/jappl.1994.77.2.998","article-title":"Cardiopulmonary adaptations to pneumonectomy in dogs. IV. Membrane diffusing capacity and capillary blood volume.","volume":"77","author":"Hsia","year":"1994","journal-title":"J Appl Physiol (1985)"},{"key":"R36-20240805","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1378\/chest.12-2107","article-title":"Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation.","volume":"143","author":"Bhorade","year":"2013","journal-title":"Chest"},{"key":"R37-20240805","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2020.08.013","article-title":"Molecular T-cell\u2013mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss.","volume":"39","author":"Halloran","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R38-20240805","doi-asserted-by":"crossref","first-page":"147610","DOI":"10.1172\/jci.insight.147610","article-title":"Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.","volume":"6","author":"Andargie","year":"2021","journal-title":"JCI Insight"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:02:29Z","timestamp":1722834149000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001317","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]}}}